Tags : Ultra Rapid Lispro

Eli Lilly Reports Results of Ultra Rapid Lispro (URLi) in

Tuba Khan June 10, 2019

Shots: The two P-III PRONTO-T1D & PRONTO-T2D studies result involves assessing of Ultra Rapid Lispro (URLi) vs Humalog (insulin lispro), both in combination with insulin glargine/degludec in 1,222 & 673 […]readmore

Tags : Ultra Rapid Lispro

Eli Lilly Reports Results of Ultra Rapid Lispro (URLi) in

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Ultra Rapid Lispro

Eli Lilly Reports Results of Ultra Rapid Lispro (URLi) in

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company